CHETAN CHANDRAKANT JARIWALA's Insider Trades & SAST Disclosures
CHETAN CHANDRAKANT JARIWALA's most recent trade in Trident Texofab Ltd. was a Acquisition of 9,253 Equity Shares done at an average price of Rs. 116 . Disclosure was reported to the exchange on July 29, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
CHETAN CHANDRAKANT JARIWALA's has made SAST transactions in Trident Texofab Ltd. recently where a Acquisition of 9,253 shares done . Disclosure was reported to the exchange on July 29, 2022.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trident Texofab | Chetan Chandrakant Jariwala | Promoter | Acquisition | 01 Aug 2022 | 9,253 | 1,517,805 (15.07%) | 0.09% | - | 28 Jul 2022 28 Jul 2022 |
SAST (29(2)) | - | Market | |
| Trident Texofab | CHETAN CHANDRAKANT JARIWALA | Promoter & Director | Acquisition | 29 Jul 2022 | 9,253 | 1,517,805 (15.07%) | 0.09% | 116 | 1,073,348 | 28 Jul 2022 28 Jul 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | CHETAN CHANDRAKANT JARIWALA | Promoter & Director | Acquisition | 28 Jul 2022 | 10,000 | 1,508,552 (14.98%) | 0.10% | 111.5 | 1,115,300 | 26 Jul 2022 26 Jul 2022 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | Chetan Chandrakant Jariwala | Promoter | Acquisition | 27 Jul 2022 | 10,000 | 1,508,552 (14.98%) | 0.09% | - | 26 Jul 2022 26 Jul 2022 |
SAST (29(2)) | - | Market | |
| Trident Texofab | Chetan Chandrakant Jariwala | Promoter | Acquisition | 06 Dec 2021 | 25,000 | 1,498,552 (14.88%) | 0.25% | - | 03 Dec 2021 03 Dec 2021 |
SAST (29(2)) | - | Market | |
| Trident Texofab | CHETAN CHANDRAKANT JARIWALA | Promoter & Director | Acquisition | 06 Dec 2021 | 25,000 | 1,498,552 (14.88%) | 0.25% | 44.3 | 1,106,250 | 03 Dec 2021 03 Dec 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | CHETAN CHANDRAKANT JARIWALA | Promoter & Director | Acquisition | 03 Nov 2021 | 45,000 | 1,473,552 (14.63%) | 0.45% | 42.0 | 1,889,997 | 03 Nov 2021 03 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | Chetan Chandrakant Jariwala | Promoter | Acquisition | 03 Nov 2021 | 45,000 | 1,473,552 (14.63%) | 0.44% | - | 03 Nov 2021 03 Nov 2021 |
SAST (29(2)) | - | Market | |
| Trident Texofab | Chetan Chandrakant Jariwala | Promoter | Acquisition | 03 Mar 2021 | 20,000 | 1,428,552 (14.19%) | 0.20% | - | 01 Mar 2021 01 Mar 2021 |
SAST (29(2)) | - | Market | |
| Trident Texofab | CHETAN CHANDRAKANT JARIWALA | Promoter & Director | Acquisition | 03 Mar 2021 | 20,000 | 1,428,552 (14.19%) | 0.20% | 25.3 | 505,000 | 01 Mar 2021 01 Mar 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | CHETAN CHANDRAKANT JARIWALA | Promoter & Director | Acquisition | 26 Feb 2021 | 35,000 | 1,408,552 (13.99%) | 0.35% | 25 | 875,000 | 25 Feb 2021 25 Feb 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Trident Texofab | Chetan Chandrakant Jariwala | Promoter | Acquisition | 19 Feb 2021 | 20,000 | 1,373,552 (13.63%) | 0.19% | - | 18 Feb 2021 18 Feb 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.